Gonax 120mg subcutaneous injection (YJ code: 2499412D4023, standard: 120mg x 1 bottle (with dissolving solution)), manufactured by Ferring Pharma, contains degarelix acetate. This GnRH antagonist is used for prostate cancer treatment by suppressing testosterone secretion, with the 120 mg dose typically used as part of the initial treatment.
Gonax 120mg subcutaneous injection
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →